4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-142027
Director sold 9,000 shares at $19.06 ($171,540)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lingnau Lutz · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-09-15 | Sale : show line 1 in the form | −9,000 | $19.06 | $171,540 | 7,450 | D |
| 2016-09-15 | Exercise or conversion : show line 2 in the form | +15,000 | 22,450 | D | ||
| Open-market sales · 9,000 sh · avg $19.06 · $171,540 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2016-09-15 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −15,000 | 15,000 | 0 | D |
Loading xslF345X03/doc4.xml…